Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,302 | -345,910 | -240,649 | -149,753 | -65,047 |
| Depreciation Amortization | 587 | 2,543 | 1,932 | 1,291 | 659 |
| Income taxes - deferred | 447 | -3,198 | -2,084 | -1,383 | -1,213 |
| Accounts receivable | 205 | 104 | 663 | 380 | -7,178 |
| Other Working Capital | -3,380 | 4,360 | -4,608 | -9,571 | -12,194 |
| Other Operating Activity | 15,546 | 62,983 | 47,109 | 33,151 | 23,321 |
| Operating Cash Flow | $-88,897 | $-279,118 | $-197,637 | $-125,885 | $-61,652 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -407,149 | 218,797 | 155,782 | 116,970 | 34,553 |
| PPE Investments | -133 | -799 | -481 | -200 | -43 |
| Investing Cash Flow | $-407,282 | $217,998 | $155,301 | $116,770 | $34,510 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 843,013 | 117,113 | 3,576 | 1,216 | 1,151 |
| Financing Cash Flow | $843,013 | $117,113 | $3,576 | $1,216 | $1,151 |
| Exchange Rate Effect | -130 | 458 | 562 | 568 | -64 |
| Beginning Cash Position | 199,163 | 142,712 | 142,712 | 142,712 | 142,712 |
| End Cash Position | 545,867 | 199,163 | 104,514 | 135,381 | 116,657 |
| Net Cash Flow | $346,704 | $56,451 | $-38,198 | $-7,331 | $-26,055 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,897 | -279,118 | -197,637 | -125,885 | -61,652 |
| Capital Expenditure | -133 | -799 | -481 | -200 | -43 |
| Free Cash Flow | -89,030 | -279,917 | -198,118 | -126,085 | -61,695 |